ID   NOY1-CR
AC   CVCL_0P32
DR   Wikidata; Q54930935
RX   PubMed=21150160;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P30 ! NOY1
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
RX   PubMed=21150160; DOI=10.1159/000320744;
RA   Shibata, Kiyosumi
RA   Umezu, Tomokazu
RA   Sakurai, Maiko
RA   Kajiyama, Hiroaki
RA   Yamamoto, Eiko
RA   Ino, Kazuhiko
RA   Nawa, Akihiro
RA   Kikkawa, Fumitaka
RT   "Establishment of cisplatin-resistant ovarian yolk sac tumor cells and
RT   investigation of the mechanism of cisplatin resistance using this cell
RT   line.";
RL   Gynecol. Obstet. Invest. 71:104-111(2011).
//